Ravi Kapur, PhD
Ravi Kapur, PhD, is a scientist, engineer, and entrepreneur with 20 years of experience in developing and commercializing nascent technologies from premier academic laboratories. He has co-founded and built successful, innovative companies in partnership with leading academics from Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), and Carnegie Mellon. Ravi co-founded the non-invasive prenatal screening company Verinata Health (acquired by Illumina) and shaped the drug discovery platform at Cellomics (acquired by Thermo Fisher). He co-directs the Innovation Ecosystem at MGH for development of microfluidic platform technologies for clinical medicine. He earned his master’s degree and doctorate in bioengineering at Clemson University and has an undergraduate degree in electrical engineering. Ravi has 23 issued and 50 pending U.S. and international patents.